Rubra Medicaments informs about standalone financial results

10 Nov 2016 Evaluate

Rubra Medicaments has informed about standalone financial results for the period ended September 30, 2016 and standalone limited review for the period ended September 30, 2016.

The above information is a part of company’s filings submitted to BSE.

Rubra Medicaments Share Price

126.60 2.45 (1.97%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 263.55
Adani Enterprises 2156.70
Amrapali Industries 14.50
Rashi Peripheral 368.00
PDS 347.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×